1Moe S,Drueke T,Cunningham J,et al.Definition,evaluation,and classification of renal osteodystrophy:A position statement from Kidney Disease:Improving Global Outcomes (KDIGO)[J].Kidney Int,2006,69:1945-1953.
2Henandez JD,Weaseling K,Salusky B.Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy[J].SeminDial,2005,18:290-295.
3Goodman WG,Goldin J,Kuizon BD,et al.Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis[J].N Engl J Med,2000,342:1478-1483.
4Block GA,Raggi P,Bellasi A,Kooienga L,Spiegel DM.Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients[J].Kidney Int,2007,71:438-441.
5Suki WN,Zabaneh R,Cangiano JL,et al.Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients[J].Kidney Int,2007,72:1130-1137.
6Curran MP,Robinson DM.Lanthanum carbonate:a review of its use in lowering serum phosphate in patients with end-stage renal disease[J].Drugs,2009;69(16):2329-49.
